Table of Contents: Volume 14, Issue 3 - September 2006
Metastatic Kidney Cancer: First-Line Sunitinib Superior to Interferon
Robert Motzer, Memorial Sloan-Kettering Cancer Center, New York
[05:46 min:sec]
Temsirolimus: More Effective Than Interferon in Patients With High-Risk Advanced Renal Cell Carcinoma
Gary Hudes, Fox Chase Cancer Center, Philadelphia
[06:15 min:sec]
Induction Chemotherapy: Significant Benefit for Patients With Advanced Head and Neck Cancer
Marshall Posner, Dana-Farber Cancer Institute, Boston
[06:10 min:sec]
Adding Thalidomide to Melphalan and Prednisone Benefits Older Patients With Multiple Myeloma
Thierry Facon, University of Lille
[06:41 min:sec]
Decreased Dose of Thalidomide: Just as Effective in Multiple Myeloma?
Ibrahim Yakoub-Agha, University of Lille
[05:16 min:sec]
Imatinib for Chronic Myeloid Leukemia: IRIS 5-Year Data
Robert Mayer, Dana-Farber Cancer Institute, Boston
[04:20 min:sec]
Raloxifene Is as Good as Tamoxifen for Preventing Breast Cancer
Lawrence Wickerham, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh & Patricia Ganz, University of California, Los Angeles
[12:03 min:sec]
Human Papillomavirus Vaccine Prevents Vaginal and Vulvar Cancers
Jorma Paavonen, University of Helsinki
[04:26 min:sec]
Salpingo-Oophorectomy: Effective Protection for BRCA1 and BRCA2 Carriers
Noah Kauff, Memorial Sloan-Kettering Cancer Center, New York
[06:48 min:sec]
Listen to this audio by subscribing to the Podcast |
|---|